About

Company description

Founded and guided by Chairman Andrea Lacorte and Managing Director Roberto Lacorte, PharmaNutra was established in 2003. The company develops unique nutraceutical supplements and innovative nutritional devices, taking care of the entire production process, from the proprietary raw materials to the finished product. The efficacy of the products has been demonstrated by numerous clinical studies, 79 of them published with more than 5.000 patients treated. The Group distributes and sells itsproducts in Italy and abroad. In Italy, products are sold through a network of 180 Pharmaceutical Representatives, serving doctors and also exclusively selling PharmaNutra's products to pharmacies throughout Italy. Products are sold in over 70 countries abroad, through 35 partners selected from among the finest pharmaceutical companies. PharmaNutra leads the market in the production of iron-based nutritional supplements under the SiderAL brand, where it boasts a number of important patents on sucrosomial technology. Over the years, the Group has developed a precise strategy for the management and production of intellectual property, founded on the integrated management of all the various elements: proprietary raw materials, patents, brands and clinical evidence.

Quick facts

Sales markets Western Europe, Eastern Europe, Middle East, Asia, North America, Africa, Central/South America
Affiliated categories: Capsules/Encapsulation |Dietary Supplement Ingredients |Finished Dosage Formulations More

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 14.1J71 See our Exhibitor Profile   See full Exhibitor List

News about Pharmanutra SpA

Sucrosomial ® Iron award-winning product of the year by Israeli consumers

19 Jul 2018

Sucrosomial ® Iron award-winning product of the year by Israeli consumers

The Sucrosomial ® technology, patent of the PharmaNutra Group at the base of the SiderAL® products, continues to gain important consents from the international markets. In fact Comfort Iron, a product launched at the beginning of 2017 exclusively for the Israeli market with a formula composed of Sucrosomial® Iron and Vitamin C, was elected by Israeli consumers “Product of the Year 2018”.

Read more

19 Jul 2018

New great success for Cetilar®: PharmaNutra obtains the patent grant

A new, fundamental strategic business asset has been added to those already owned by PharmaNutra SPA. On 5 February 2018 the company received from the Italian Patent Office the patent grant for Cetilar ® RM (number 102015000044822).

Read more

19 Jul 2018

International Multidisciplinary Course on Iron Deficiency 2018: the results of the 6th edition

On April 13th and 14th Lisbon was the scene of the sixth edition of the International Multidisciplinary Course on Iron Deficiency (IMCID), organized as every year by PharmaNutra SPA in collaboration with Zambon, the company’s trading partner in the Iberian Peninsula markets. Among its participants, the Congress saw experts doctors and researchers from more than 20 different countries, confirming the real in...

Read more

19 Jul 2018

PharmaNutra’s growth one year from listing on the Stock Exchange

Double-digit growth, appreciation in the share value and a significant market cap increase: just 12 months since its listing, the Pharmanutra Group records a marked upswing on the market and prepares for new challenges

Read more
Pharmanutra SpA

Contact information

Address

Telephone

Website

View all contact information